NCT04971031Phase 2Completed

A Clinical Trial to Assess Subjects With Dry Eye Disease.

Study sponsor: Aldeyra Therapeutics, Inc. · ALDX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-09-08Actual
Enrollment · participants158Actual
Source updated2025-02-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.